A RANDOMIZED TRIAL OF ANTICOAGULATION WITH WARFARIN AND OF ALTERNATING CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER BY THE CANCER AND LEUKEMIA GROUP-B

被引：180
作者：
CHAHINIAN, AP
PROPERT, KJ
WARE, JH
ZIMMER, B
PERRY, MC
HIRSH, V
SKARIN, A
KOPEL, S
HOLLAND, JF
COMIS, RL
GREEN, MR
机构：
[1] FRONTIER SCI & TECHNOL RES FDN INC,AMHERST,NY
[2] ROYAL VICTORIA HOSP,MONTREAL H3A 1A1,QUEBEC,CANADA
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115
[4] MAIMONIDES HOSP,DIV HEMATOL ONCOL,BROOKLYN,NY 11219
[5] CUNY MT SINAI SCH MED,DEPT NEOPLAST DIS,NEW YORK,NY 10029
[6] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115
[7] UNIV MISSOURI,MED CTR,SCH MED,DEPT MED,COLUMBIA,MO 65201
[8] FOX CHASE CANC INST,PHILADELPHIA,PA 19111
[9] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[10] UNIV CALIF SAN DIEGO,CTR CANC,LA JOLLA,CA 92093
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 08期
关键词：
D O I：
10.1200/JCO.1989.7.8.993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：993 / 1002
页数：10
相关论文
共 21 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS
[2]  
CHAHINIAN AP, 1982, B CANCER, V69, P79
[3]   MITOMYCIN-C, ETOPOSIDE, CISPLATIN, AND HEXAMETHYLMELAMINE (MEPH) AS A 2ND-LINE REGIMEN IN LUNG-CANCER [J].
CHAHINIAN, AP ;
GREEN, G ;
HOLLAND, JF .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05) :419-423
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   CYCLIC ALTERNATING NON-CROSS RESISTANT CHEMOTHERAPY IN THE MANAGEMENT OF SMALL CELL ANAPLASTIC CARCINOMA OF THE LUNG [J].
ELLIOTT, JA ;
OSTERLIND, K ;
HANSEN, HH .
CANCER TREATMENT REVIEWS, 1984, 11 (02) :103-113
[6]   SUPERIORITY OF ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY IN EXTENSIVE SMALL-CELL LUNG-CANCER - A MULTICENTER, RANDOMIZED CLINICAL-TRIAL BY THE NATIONAL-CANCER-INSTITUTE-OF-CANADA [J].
EVANS, WK ;
FELD, R ;
MURRAY, N ;
WILLAN, A ;
COY, P ;
OSOBA, D ;
SHEPHERD, FA ;
CLARK, DA ;
LEVITT, M ;
MACDONALD, A ;
WILSON, K ;
SHELLEY, W ;
PATER, J .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) :451-458
[7]  
GOLDIE JH, 1982, CANCER TREAT REP, V66, P439
[8]  
GOLDIE JH, 1984, CANCER RES, V44, P3643
[9]  
LIVINGSTON RB, 1986, CANCER TREAT REP, V70, P1395
[10]   COMBINED MODALITY THERAPY WITH RADIOTHERAPY, CHEMOTHERAPY, AND IMMUNOTHERAPY IN LIMITED SMALL-CELL CARCINOMA OF THE LUNG - A PHASE-III CANCER AND LEUKEMIA GROUP-B STUDY [J].
MAURER, LH ;
PAJAK, T ;
EATON, W ;
COMIS, R ;
CHAHINIAN, P ;
FAULKNER, C ;
SILBERFARB, PM ;
HENDERSON, E ;
REGE, VB ;
BALDWIN, PE ;
WEISS, R ;
RAFLA, S ;
PRAGER, D ;
CAREY, R ;
PERRY, M ;
CHOI, NC .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) :969-976
123